Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale

von Thomas George · 10.10.2018

Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale
GW Pharmaceuticals (NASDAQ: GWPH), maker of the epilepsy treatment Epidiolex, has raised $345 million to fund an expansion drive. #marijuanastocks #potstocks

Read the full article

Thomas George

Zur Person

Aurora Cannabis Applies To Trade On NYSE
MGC Pharmaceuticals' Shares Soar After Australia Export Win
WestJet Airlines To Prohibit
Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale
Legal Cannabis Supply Will Only Meet 30-60% of Demand
New Zealand's First Cannabis Cultivation Plant Given the Green Light
Leadership, Execution and Growth - Interview with Aphria's CEO Vic Neufeld
Medical Marijuana Gets Religious Backing in Utah — Could Lead to Legalization
Only 2 Stores Approved to Sell Marijuana in Calgary On Oct. 17

Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale

Thomas George

Aurora Cannabis Applies To Trade On NYSE

MGC Pharmaceuticals' Shares Soar After Australia Export Win

WestJet Airlines To Prohibit

Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale

Legal Cannabis Supply Will Only Meet 30-60% of Demand

New Zealand's First Cannabis Cultivation Plant Given the Green Light

Leadership, Execution and Growth - Interview with Aphria's CEO Vic Neufeld

Medical Marijuana Gets Religious Backing in Utah — Could Lead to Legalization

Only 2 Stores Approved to Sell Marijuana in Calgary On Oct. 17

Thomas George

Impressum

Kontakt